1. Home
  2. ALDX

as 05-24-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Founded: 2004 Country:
United States
United States
Employees: N/A City: LEXINGTON
Market Cap: 234.1M IPO Year: 2014
Target Price: $9.33 AVG Volume (30 days): 560.1K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.51 EPS Growth: N/A
52 Week Low/High: $1.42 - $11.97 Next Earning Date: 05-02-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 57.57%

ALDX Daily Stock ML Predictions

Stock Insider Trading Activity of Aldeyra Therapeutics Inc. (ALDX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
PERCEPTIVE ADVISORS LLC ALDX 10% Owner Apr 4 '24 Buy $4.67 140,281 $655,112.27 9,238,139 SEC Form 4
PERCEPTIVE ADVISORS LLC ALDX 10% Owner Apr 4 '24 Buy $4.74 37,712 $178,754.88 9,275,851 SEC Form 4
Greenberg Bruce ALDX See Remarks Mar 11 '24 Sell $3.41 13,201 $44,967.89 130,154 SEC Form 4
Brady Todd C ALDX President and CEO Mar 9 '24 Sell $3.05 85,324 $260,238.20 1,471,298 SEC Form 4
Brady Todd C ALDX President and CEO Mar 9 '24 Sell $3.27 97,914 $320,521.48 1,556,622 SEC Form 4
Machatha Stephen ALDX Chief Development Officer Mar 9 '24 Sell $3.16 11,537 $36,503.07 243,495 SEC Form 4
Machatha Stephen ALDX Chief Development Officer Mar 9 '24 Sell $3.41 18,231 $62,102.08 255,032 SEC Form 4
Greenberg Bruce ALDX See Remarks Mar 9 '24 Sell $3.41 13,201 $44,967.89 120,699 SEC Form 4

Share on Social Networks: